| Literature DB >> 32669498 |
Abstract
Objective The triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio is related to insulin resistance (IR). However, information about whether or not the TG/HDL-C ratio is associated with low-density lipoprotein (LDL) subclasses in the Japanese population is limited. Methods In total, 1,068 Japanese subjects who underwent an annual health examination and who were not taking medications were recruited. The association between the TG/HDL-C ratio and LDL subclasses was investigated using correlation, multiple regression, and receiver operating characteristic analyses. Results A correlation analysis revealed that both malondialdehyde-modified low-density lipoprotein (MDA-LDL) and small dense low-density lipoprotein cholesterol (sdLDL-C) were positively associated with the TG/HDL-C ratio. Furthermore, a multiple linear regression analysis revealed that the TG/HDL-C ratio was positively associated with MDA-LDL and sdLDL-C in both men and women. The multiple logistic regression analysis also revealed that the TG/HDL-C ratio was positively associated with the upper tertile of MDA-LDL and sdLDL-C in men and women. The LDL-C levels increased with the increasing TG/HDL-C ratio. The MDA-LDL and sdLDL-C are known to be positively associated with LDL-C. However, within the same LDL-C range, both MDA-LDL and sdLDL-C levels increased with the TG/HDL-C ratio, except for MDA-LDL levels in the LDL-C <112 mg/dL group in women. These results further supported the notion that the TG/HDL-C ratio was positively associated with the MDA-LDL and sdLDL-C levels, especially in the higher LDL-C range, in both men and women. The optimal cut-off points of the TG/HDL-C ratio for the upper tertile of MDA-LDL and sdLDL-C were 1.85 and 2.03 in men and 0.88 and 1.30 in women, respectively. Conclusion The TG/HDL-C ratio is positively associated with MDA-LDL and sdLDL-C in Japanese subjects. The relationship was particularly notable in subjects with high LDL-C levels.Entities:
Keywords: malondialdehyde-modified low-density lipoprotein; small dense low-density lipoprotein cholesterol; triglyceride to high-density lipoprotein cholesterol ratio
Year: 2020 PMID: 32669498 PMCID: PMC7691041 DOI: 10.2169/internalmedicine.4954-20
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Characteristics of Study Subjects.
| Men (n=651) | Women (n=417) | |||
|---|---|---|---|---|
| Age | 55.5±12.1 | 57.6±11.7* | ||
| BMI (kg/m2) | 23.8±3.2 | 21.7±2.9** | ||
| Waist circumference (cm) | 84.1±8.5 | 78.1±8.5** | ||
| Systolic BP (mmHg) | 122.0±17.0 | 117.8±19.0** | ||
| Diastolic BP (mmHg) | 78.5±12.8 | 71.6±12.3** | ||
| FPG (mg/dL) | 102.9±18.9 | 98.2±18.6** | ||
| FIRI (μIU/mL) | 6.24±4.64 | 5.08±2.99** | ||
| HOMA-IR | 1.64±1.57 | 1.27±0.94** | ||
| TG (mg/dL) | 103.0 [73.0,147.0] | 73.0 [55.0,103.0]** | ||
| HDL-C (mg/dL) | 59.4±14.5 | 76.4±16.8** | ||
| TG to HDL-C ratio | 1.74 [1.13,2.89] | 0.95[0.67,1.53]** | ||
| LDL-C (mg/dL) | 121.6±30.7 | 127.2±33.3* | ||
| non-HDL-C (mg/dL) | 146.3±34.1 | 143.9±35.9 | ||
| UA (mg/dL) | 6.3±1.2 | 4.6±0.94** | ||
| MDA-LDL (U/L) | 142.4±43.0 | 121.0±41.0** | ||
| sdLDL-C (mg/dL) | 40.0±16.8 | 32.9±13.2** | ||
| hsCRP (mg/dL) | 0.04 [0.02,0.09] | 0.03 [0.02,0.07] |
Variables are given as means±standard deviations or median [inter-quartile range]. BMI: body mass index, BP: blood pressure, FPG: fasting plasma glucose, FIRI: fasting immunoreactive insulin, HOMA-IR: homeostasis model assessment-insulin resistance, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, non-HDL-C: non high-density lipoprotein cholesterol, UA: uric acid, MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, hsCRP: high-sensitivity C-reactive protein
**p<0.01, *p<0.05 by paired t-test.
Figure 1.Scatter plots and regression lines for the comparisons of MDA-LDL and sdLDL-C levels (a, c: men and b, d: women) and ln (TG/HDL-C). Pearson’s correlation coefficient with 95% confidence intervals is indicated on the graph. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, ln (TG/HDL-C): logarithmic transformed triglyceride to high-density lipoprotein cholesterol ratio
Multiple Linear Regression Analysis for the MDA-LDL and sdLDL-C.
| (a) Men | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| MDA-LDL | sdLDL-C | ||||||||
| RC | SRC | t | p | RC | SRC | t | p | ||
| BMI | 2.43897 | 0.17940 | 4.58 | <0.0001 | 0.89203 | 0.16791 | 4.96 | <0.0001 | |
| TG/HDL-C | 4.99563 | 0.23936 | 6.11 | <0.0001 | 4.13176 | 0.50659 | 14.97 | <0.0001 | |
| Variable selection was made by a stepwise procedure. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, RC: regression coefficient, SRC: standardized regression coefficient, BMI: body mass index, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol | |||||||||
| Age | 0.72496 | 0.206.3 | 4.55 | <0.0001 | 0.12239 | 0.10828 | 2.69 | 0.0074 | |
| WC | 0.83574 | 0.17278 | 3.62 | 0.0003 | 0.18355 | 0.11814 | 2.72 | 0.0067 | |
| Diastolic BP | ---- | ---- | ---- | ---- | 0.12097 | 0.11295 | 2.79 | 0.0056 | |
| FPG | 0.32901 | 0.14922 | 3.26 | 0.0012 | 0.10325 | 0.14578 | 3.60 | 0.0004 | |
| TG/HDL-C | 10.00933 | 0.20149 | 4.35 | <0.0001 | 7.36252 | 0.46141 | 11.27 | <0.0001 | |
| Variable selection was made by a stepwise procedure. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, RC: regression coefficient, SRC: standardized regression coefficient, WC: waist circumference, BP: blood pressure, FPG: fasting plasma glucose, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol | |||||||||
Multiple Logistic Regression Analysis for the Upper Tertile of MDA-LDL and sdLDL-C.
| (a) Men | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper tertile of MDA-LDL | Upper tertile of sdLDL-C | ||||||||||
| RC | SE | OR | 95% CI | p | RC | SE | OR | 95% CI | p | ||
| Age | -0.0254 | 0.0078 | 0.975 | 0.960-0.990 | 0.0011 | ---- | ---- | ---- | ---- | ---- | |
| Systolic BP | 0.0157 | 0.0054 | 1.016 | 1.005-1.027 | 0.0034 | ---- | ---- | ---- | ---- | ---- | |
| BMI | ---- | ---- | ---- | ---- | ---- | 0.0867 | 0.0350 | 1.091 | 1.018-1.168 | 0.0133 | |
| TG/HDL-C | 0.2687 | 0.0500 | 1.308 | 1.186-1.443 | <0.0001 | 0.9297 | 0.0908 | 2.527 | 2.115-3.020 | <0.0001 | |
| Variable selection was made by a stepwise procedure. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, RC: regression coefficient, SE: standard error, OR: odds ratio, CI: confidence interval, WC: waist circumference, BP: blood pressure, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol | |||||||||||
| Age | 0.0442 | 0.0109 | 1.045 | 1.023-1.068 | <0.0001 | 0.0248 | 0.0109 | 1.025 | 1.004-1.047 | 0.0225 | |
| WC | 0.0580 | 0.0147 | 1.060 | 1.030-1.091 | <0.0001 | 0.0455 | 0.0152 | 1.047 | 1.016-1.078 | 0.0028 | |
| Diastolic BP | ---- | ---- | ---- | ---- | ---- | 0.0229 | 0.0100 | 1.023 | 1.003-1.043 | 0.0221 | |
| TG/HDL-C | 0.6275 | 0.1569 | 1.873 | 1.377-2.547 | <0.0001 | 0.9607 | 0.1701 | 2.613 | 1.873-3.647 | <0.0001 | |
| Variable selection was made by a stepwise procedure. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, RC: regression coefficient, SE: standard error, OR: odds ratio, CI: confidence interval, BP: blood pressure, BMI: body mass index, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol | |||||||||||
Figure 2.A bar graph of the mean LDL-C values with 95% confidence intervals after stratifying the subjects according to sex and TG/HDL-C values. LDL-C: low-density lipoprotein cholesterol, TG/HDL-C: triglyceride to high-density lipoprotein cholesterol ratio. **p<0.01 according to Bonferroni’s multiple comparison test
Figure 3.A bar graph of the mean MDA-LDL and sdLDL-C levels (a, c: men and b, d: women) with 95% confidence intervals after stratifying the subjects according to sex, the TG/HDL-C ratio, and LDL-C values. MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, TG/HDL-C: triglyceride to high-density lipoprotein cholesterol ratio. *p<0.05, **p<0.01 according to Bonferroni’s multiple comparison test.
Figure 4.The ROC curves of the TG/HDL-C ratio for predicting the upper tertile of the MDA-LDL and sdLDL-C levels. The AUC with its 95% CI and optimal cut-off point (sensitivity, specificity) for the TG/HDL-C ratio are shown in the graph. ROC: receiver operator characteristic, TG/HDL-C: triglyceride to high-density lipoprotein cholesterol ratio, MDA-LDL: malondialdehyde-modified low-density lipoprotein, sdLDL-C: small-dense low-density lipoprotein cholesterol, AUC: area under the curve, CI: confidence interval